Cited by 76Gastrointestinal motility and disordersAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesInfant Health and Development

Rapid Response to Cognitive Behavior Therapy Predicts Treatment Outcome in Patients With Irritable Bowel Syndrome

Open access
Lackner, Jeffrey M., Gudleski, Gregory D., Keefer, Laurie, Krasner, Susan S., Powell, Cathrine, Katz, Leonard A.·2010·Clinical Gastroenterology and Hepatology

Abstract

Background We sought to determine whether the therapeutic phenomenon of rapid response characterizes patients undergoing CBT for irritable bowel syndrome (IBS). If RR is operating in IBS treatment, a significant proportion of CBT treated patients should achieve a positive response early in treatment (by week 4). We also hypothesized that rapid responders (RR) would be more likely to maintain treatment gains than non rapid responders (NRR). Our secondary goal was to characterize the psychosocial profile of RRs on clinically relevant demographic and clinical variables (e.g., health status, baseline level of IBS symptom severity, distress). Methods 71 individuals ages 18–70 years with a Rome II IBS diagnosis and symptoms of at least moderate severity were randomized to one of 2 CBT treatments: either 10 weekly, one hour sessions (Standard-CBT) or four, one hour sessions over 10 weeks (Minimal Contact-CBT). RRs were classified as patients who 1) reported adequate relief of pain; 2), adequate relief of GI symptoms and 3) a decrease in total IBSSS scores of ≥50 by week 4. Results 30% of CBT treated patients achieved RR by week 4 of treatment. 90–95% of RRs maintained gains at immediate and 3 month follow-up. While RR reported more severe IBS symptoms at baseline, they achieved more substantial and sustained gains (e.g. IBS symptom reduction) than NRRs. Standard- and MC CBT yielded comparable RR rates even though MC CBT patients received 50% less clinic treatment by week 4. Conclusions Rapid response is a potentially important prognostic outcome indicator that has important implications for developing step care approaches for IBS treatment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cgh.2010.02.007

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

4 of the 51 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Lackner, J. M., Gudleski, G. D., Keefer, L., Krasner, S. S., Powell, C., & Katz, L. A.
Affiliations
  • University at Buffalo, State University of New York (US)
  • Northwestern University (US)
Corresponding author
Lackner, Jeffrey M.
Venue
Clinical Gastroenterology and Hepatology
Publisher
Elsevier BV
Published
2010-05
Volume
8
Issue
5
Pages
426-432
ISSN
1542-3565 (ISSN-L)
OpenAlex
W2024448573
Cited by
76
References
51
Citations by year
2026: 1 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 5 · 2021: 6 · 2020: 4 · 2019: 2 · 2018: 8 · 2017: 6 · 2016: 3 · 2015: 5 · 2014: 5 · 2013: 7 · 2012: 8
FWCI
7.57
Type
journal article
Language
en
Open access
Locations
  • Clinical Gastroenterology and Hepatology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (77738)
  • U.S. Public Health Service (67878, 77738)
  • National Institute of Diabetes and Digestive and Kidney Diseases (U01DK077738, R03DK067878)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Health Professions › Pharmacy › Infant Health and Development
Keywords
irritable bowel syndrome, cognitive behavioral therapy, rapid response, treatment outcomes, symptom severity, maintenance of treatment gains, psychosocial profile, treatment dosage, analgesia, bowel symptoms
MeSH terms
Adolescent, Adult, Aged, Female, Humans, Male, Middle Aged, Severity of Illness Index, Cognitive Behavioral Therapy, Treatment Outcome, Irritable Bowel Syndrome, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review